Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1519-1527
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nørgaard, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nørgaard, B. L.

CLINICAL STUDIES

Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring

Bjarne L. Nørgaard, MDa, Karl Andersen, MD*, Mikael Dellborg, MD*, Putte Abrahamsson, MD*, Jan Ravkilde, MDa, Kristian Thygesen, MD, FACCa for the TRIM study group

a Department of Medicine and Cardiology, Aarhus University Hospital, Aarhus, Denmark
* Department of Medicine and Cardiology, Sahlgrenska University Hospital, Ôstra, Gothenburg, Sweden

Manuscript received October 30, 1997; revised manuscript received January 6, 1999, accepted January 21, 1999.

Reprint requests and correspondence: Dr. Bjarne Linde Nørgaard, Department of Medicine and Cardiology, Aarhus University Hospital, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark
bnorgaard{at}dadlnet.DK

OBJECTIVES

We investigated whether the addition of 24 h of continuous vectorcardiography ST segment monitoring (cVST) for an early (within 24 h of the latest episode of angina) determination of cardiac troponin T (cTnT) could provide additional prognostic information in patients with unstable coronary artery disease (UCAD), i.e., unstable angina and non–Q wave myocardial infarction.

BACKGROUND

Determination of cTnT at admission and cVST are individually reported to be valuable techniques for the risk assessment of patients with UCAD.

METHODS

Two hundred and thirty-two patients suspected of UCAD were studied. Patients were followed for 30 days, and the occurrence of cardiac death or acute myocardial infarction (AMI) were registered.

RESULTS

One ST segment episode or more (relative risk [RR] 7.43, p = 0.012), a cTnT level ≥0.20 µg/liter (RR 3.85, p = 0.036) or prestudy medication with calcium antagonists (RR 3.31, p = 0.041) were found to carry independent prognostic information after multivariate analysis of potential risk variables. By combining a cTnT determination and subsequent cVST for 24 h, subgroups of patients at high (25.8%) (n = 31), intermediate (3.1%) (n = 65) and low risk (1.7%) (n = 117) of death or AMI could be identified.

CONCLUSIONS

Twenty-four hours of cVST provides additional prognostic information to that of an early cTnT determination in patients suspected of having UCAD. The combination of biochemical and electrocardiographic methods provides powerful and accurate risk stratification in UCAD.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  CABG = coronary artery bypass grafting
  cTnT = cardiac troponin T
  cVST = continuous vectorcardiography ST segment monitoring
  ECG = electrocardiogram
  nQMI = non–Q wave myocardial infarction
  ST-VM = ST vector magnitude
  UAP = unstable angina pectoris
  UCAD = unstable coronary artery disease




This article has been cited by other articles:


Home page
Crit Care NurseHome page
K. E. Sandau and M. Smith
Continuous ST-Segment Monitoring: Protocol for Practice
Crit. Care Nurse, August 1, 2009; 29(4): 39 - 49.
[Full Text] [PDF]


Home page
QJMHome page
T. Richardson, J. Baker, P.W. Thomas, C. Meckes, A. Rozkovec, and D. Kerr
Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction
QJM, August 1, 2009; 102(8): 555 - 561.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
M. Dweck, I. W Campbell, D. Miller, and C M. Francis
Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus
The British Journal of Diabetes & Vascular Disease, May 1, 2009; 9(3): 110 - 116.
[Abstract] [PDF]


Home page
Crit Care NurseHome page
M. Jahrsdoerfer, K. Giuliano, and D. Stephens
Clinical Usefulness of the EASI 12-Lead Continuous Electrocardiographic Monitoring System
Crit. Care Nurse, October 1, 2005; 25(5): 28 - 37.
[Full Text] [PDF]


Home page
HeartHome page
B L Norgaard, K Andersen, K Thygesen, J Ravkilde, P Abrahamsson, L Grip, and M Dellborg
Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring
Heart, July 1, 2004; 90(7): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. F. Cohn, K. M. Fox, and C. Daly
Silent Myocardial Ischemia
Circulation, September 9, 2003; 108(10): 1263 - 1277.
[Full Text] [PDF]


Home page
Eur Heart JHome page
O. Manfrini, C. Pizzi, D. Trere, F. Fontana, and R. Bugiardini
Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction
Eur. Heart J., September 1, 2003; 24(17): 1560 - 1566.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L.K Newby, M.V Bhapkar, H.D White, E.J Topol, F.C Dougherty, R.A Harrington, M.C Smith, L.F Asarch, R.M Califf, and for the SYMPHONY and 2nd SYMPHONY Investigators
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes
Eur. Heart J., January 2, 2003; 24(2): 172 - 181.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Kennon, C P Price, P G Mills, P K MacCallum, J Cooper, J Hooper, H Clarke, and A D Timmis
Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers
Heart, January 1, 2003; 89(1): 36 - 41.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Jernberg, P. Abrahamsson, B. Lindahl, P. Johanson, L. Wallentin, and M. Dellborg
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment
Eur. Heart J., July 2, 2002; 23(14): 1093 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Jernberg, B. Lindahl, and L. Wallentin
Continuous multilead ST-segment monitoring should be a part of the clinical routine
Eur. Heart J., June 2, 2002; 23(12): 918 - 921.
[Full Text] [PDF]


Home page
Eur Heart JHome page
K.M. Akkerhuis, P.A.J. Klootwijk, W. Lindeboom, V.A.W.M. Umans, S. Meij, P.-P. Kint, and M.L. Simoons
Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients
Eur. Heart J., November 1, 2001; 22(21): 1997 - 2006.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. A. O'Rourke, J. S. Hochman, M. C. Cohen, C. L. Lucore, J. J. Popma, and C. P. Cannon
New Approaches to Diagnosis and Management of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction
Arch Intern Med, March 12, 2001; 161(5): 674 - 682.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T Jernberg, B Lindahl, and L Wallentin
The combination of a continuous 12-lead ECG and troponin T. A valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG
Eur. Heart J., September 1, 2000; 21(17): 1464 - 1472.
[Abstract] [PDF]


Home page
Eur Heart JHome page
K. Thygesen and J. Ravkilde
Triage of chest pain patients based on early risk stratification using sensitive cardiac markers
Eur. Heart J., March 1, 2000; 21(5): 347 - 348.
[PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement